Richard Epstein, Health Affairs
"The ACA is a classic illustration of placing a persuasive title on a controversial statute to conceal its deep internal weaknesses. There is no way that one can “protect patients” by restricting, either through private employers or public exchanges, the choices they have in the type of plans they can join. It would be impossible for the statute to make health care more affordable when it piles major mandates on private plans, which could make them too costly to operate at all."
Michael Ramlet, Robert Book, & Han Zhong, American Action Forum
"To develop a more conservative projection of the likely reduction in employment, we estimated the relationship
between revenue and employment in the industry. Through our analysis, we found that an average of 1.274 direct
industry jobs and 2.210 indirect jobs are lost per year for each $1 million reduction in industry revenue that year."
Rita E. Numerof, Ph.D., The Galen Institute
"The purpose of this paper is to describe why the health insurance exchanges defined in PPACA won’t
work, won’t increase access to affordable health care, and won’t do anything to improve health
outcomes or increase value. The solution to affordable coverage isn’t to be found in these new
bureaucracies, but rather in reducing barriers to competition and consumer choice and removing
regulations that make coverage unaffordable today."
Ken Hershey, Medical Progress Today
"This case thus illustrates a serious danger latent in the "comparative effectiveness research" approach taken by the Patient Protection and Affordable Care Act: mass studies of how different treatments affect large swaths of people are not likely to pick up the subtleties and nuances in treatment effectiveness that can vary from person to person based on a whole range factors that determine each individual's unique biochemistry."
Scott Gottlieb, M.D., House Judiciary Subcommittee on Intellectual Property, Competition and the Internet Testimony
"[T]he only sure way that we’re going to
bend the cost curve is by coming up with fundamentally new ways to deliver
healthcare services that improve efficiencies and enable us to get more medical care
for each dollar we spend. These ideas are going to come forward the same way
better ideas have always arisen – from start-ups backed by entrepreneurs,
supported by investment capital, coming together in search of profits. Yet PPACA
contains provisions that I fear tilt against these kinds of innovations. The legislation
relies instead on arrangements that could serve to entrench existing players."
Charles Blahous, e21: Economic Policies for the 21st Century
"Last week the Mercatus Center published my study showing that the health care law of 2010 (the ACA) will add at least $340 billion to federal deficits over the next ten years, and more than $1.15 trillion to net federal spending. The study has received a great deal of attention, which has highlighted the need for wider public understanding of federal budget procedures. In this article I will explain some of those budget rules while further substantiating that my basic conclusion is correct."
James Capretta, e21: Economic Policies for the 21st Century
"In March, the CBO released a new study on employee migration out of job-based plans and into Obamacare’s state exchanges. The effect of ObamaCare on employer-based insurance has been hotly debated ever since the law was enacted in March 2010. Several independent analysts predict that 'dumping' into the exchanges will occur at a much higher rate than CBO assumed in its original estimates of ObamaCare and argued that the result would be much higher federal costs than CBO estimated."
e21 Staff Editorial, e21: Economic Policies for the 21st Century
"Absent the mandate, ObamaCare will not function as intended because the program’s coverage guarantee and expansion is financed, in part, through cross-subsidies generated by mandating that individuals purchase insurance policies that cost several times more than their expected insurance claims. Defenders of ObamaCare rationalize these compulsory transfers as inherent to “insurance,” which they erroneously present as a system where low-risk policyholders are expected to overpay for their coverage to reduce the cost of the policies for those with predictably high claims."
Kathryn Nix, The Heritage Foundation
"One element of the Patient Protection and Affordable Care Act (PPACA) is the advancement of 'comparative effectiveness research' (CER). Intended to compare available treatment options, CER can benefit patients if used for informational purposes only, but it could also be harmful in practice. The expansion of the Medicare bureaucracy under the PPACA will allow the use of CER for more government micromanagement of personal medical decision making—hurting patients, doctors, and the practice of medicine."
Karen E. Joynt, M.D., M.P.H., & Ashish K. Jha, M.D., M.P.H., The New England Journal of Medicine
"As part of the Affordable Care Act (ACA), Congress directed the Centers for Medicare and Medicaid Services (CMS) to penalize hospitals with 'worse than expected' 30-day readmission rates. This part of the law has stimulated hospitals, professional societies, and independent organizations to invest substantial resources in finding and implementing solutions for the 'readmissions problem.' Although a focus on readmissions may have good face validity, we believe that policymakers' emphasis on 30-day readmissions is misguided, for three reasons."